DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Needham Maintains Buy on Heron Therapeutics, Lowers Price Target to $44

Needham maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and lowers the price target from $48 to $44.

Benzinga · 03/02/2020 17:36

Needham maintains Heron Therapeutics (NASDAQ:HRTX) with a Buy and lowers the price target from $48 to $44.